IP Library Granted Patent US 8,790,267
Granted Patent B2
US 8,790,267 · App. 12/673,037 · Granted Jul 29, 2014

Dynamically variable filter

Inventors: Hanan Keren (Kfar-Saba, IL); Yoav Avidor (Tel-Aviv, IL); Pierre Squara (Enghien-les-Bains, FR); Daniel Burkhoff (West Harrison, NY); Baruch Levy (Tel Aviv, IL)
Assignee: Cheetah Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,790,267
App. No.
12/673,037
Granted
Jul 29, 2014
Kind
B2
Abstract

A method of processing a signal pertaining to at least one electrical property of an organ of a subject is disclosed. The method comprises determining a physiological condition of the subject, selecting a frequency band, filtering the signal according to the frequency band, and dynamically adapting the frequency band in response to a change in the physiological condition.

Claims (40)

1. A method of analyzing an input radiofrequency signal sensed from an organ of a subject, comprising:

processing said input radiofrequency signal to provide a processed input signal, wherein said processing comprises determining a phase shift of said input signal relative to an output radiofrequency signal transmitted to the organ;

filtering said processed signal using a dynamically variable band pass filter, thereby providing a filtered signal; and

using said filtered signal and said phase shift for calculating at least one of: a stroke volume, a cardiac output, a brain intra luminal blood volume and blood flow;

wherein the method further comprising executing an iterative process to dynamically update an upper frequency bound of said filter in response to a change in a physiological condition of the subject.

2. The method of claim 1 , wherein said possessing comprises filtering said input radiofrequency signal using an analog filter.

3. The method of claim 1 , wherein said blood flow comprises at least one of: an external carotid blood flow rate, an internal carotid blood flow rate, an ulnar blood flow rate, a radial blood flow rate, a brachial blood flow rate, a common iliac blood flow rate, an external iliac blood flow rate, a posterior tibial blood flow rate, an anterior tibial blood flow rate, a peroneal blood flow rate, a lateral plantar blood flow rate, a medial plantar blood flow rate and a deep plantar blood flow rate.

4. The method of claim 1 , further comprising transmitting said output radiofrequency signal to the organ and sensing said input radiofrequency signal from the organ.

5. The method of claim 1 , further comprising reducing or eliminating amplitude modulation of said input radiofrequency signal, so as to provide a signal of substantially constant envelope.

6. The method of claim 5 , wherein said reducing or eliminating said amplitude modulation comprises maintaining a phase modulation of said input radiofrequency signal.

7. The method of claim 1 , wherein said physiological condition is a heart rate of the subject.

8. The method of claim 7 , wherein at least one of a lower frequency bound and an upper frequency bound characterizing said filter is a linear function of said heart rate.

9. The method of claim 8 , wherein said lower frequency bound is about 0.9*(HR/60) Hz at all times, wherein said HR is said heart rate in units of beats per minute.

10. The method of claim 7 , wherein said heart rate is determined from an ECG signal received from said subject.

11. The method of claim 7 , wherein an initial value of said upper frequency bound in said iterative process is a linear function of said heart rate.

12. The method of claim 11 , wherein an initial value of said upper frequency bound in said iterative process is about 6+1.5*[(HR/60)−1] Hz, wherein said HR is said heart rate in units of beats per minute.

13. The method of claim 1 , wherein said iterative process is based on a comparison between a value of a physiological parameter as extracted from said filtered input signal and a value of said physiological parameter as extracted from a reference signal.

14. The method of claim 13 , wherein said reference signal comprises an ECG signal.

15. The method of claim 13 , wherein each iteration of said iterative process comprises:

if said comparison meets a predetermined criterion, then updating said upper frequency bound by calculating an average between a low threshold and a high threshold;

said thresholds being predetermined or set in a previous iteration of said iterative process.

16. The method of claim 13 , wherein said physiological parameter is a ventricular ejection time (VET).

17. The method of claim 16 , wherein said VET is averaged over a plurality of heart beats.

18. The method of claim 16 , wherein said VET is extracted from an average heart beat morphology of the subject.

19. The method of claim 1 , wherein said input radiofrequency signal is indicative of impedance of the organ.

20. The method of claim 1 , wherein said input radiofrequency signal is indicative of hemodynamic reactance of the organ.

21. Apparatus for analyzing an input radiofrequency signal sensed from an organ of a subject, comprising:

an input unit for receiving the input radiofrequency signal;

a signal processing circuit configured for processing said input radiofrequency signal to provide a processed input signal, said processing unit comprising a phase shift determinator configured for determining a phase shift of said input signal relative to an output radiofrequency signal transmitted to the organ;

a filtering unit configured for filtering said processed signal using a dynamically variable band pass filter, to thereby provide a filtered signal; and

a data processor having a circuit configured for applying an iterative process to dynamically update an upper frequency bound of said filter in response to a change in a physiological condition of the subject, and for calculating at least one quantity based on said phase shift, wherein said at least one quantity is selected from the group consisting of a stroke volume, a cardiac output, a brain intra luminal blood volume and blood flow.

22. The apparatus of claim 21 , wherein said physiological condition is a heart rate of the subject.

23. The apparatus of claim 22 , wherein an initial value of said upper frequency bound in said iterative process is a linear function of said heart rate.

24. The apparatus of claim 23 , wherein an initial value of said upper frequency bound in said iterative process is about 6+1.5*[(HR/60)−1] Hz, wherein said HR is said heart rate in units of beats per minute.

25. The apparatus of claim 21 , wherein said signal processing unit comprises an envelope elimination unit designed and configured to reduce or eliminate amplitude modulation of said filtered signal, so as to provide a signal of substantially constant envelope.

26. The apparatus of claim 25 , wherein said envelope elimination unit is designed and configured to maintain a phase modulation of said signal.

27. A system for monitoring at least one electrical property of an organ of a subject, comprising:

a radiofrequency generator for generating an output radiofrequency signal;

a plurality of electrodes, designed to be connectable to the skin of the subject, said electrodes being for transmitting said output radiofrequency signal to the organ and for sensing an input radiofrequency signal from the organ; and

the apparatus according to claim 21 .

Assignments (7)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 21, 2020
From: CHEETAH MEDICAL, INC.
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE SA
Reel/Frame 053268/0682 →
SECURITY INTEREST Recorded Jan 16, 2019
From: CHEETAH MEDICAL, INC.
To: SWK FUNDING LLC, AS AGENT
Reel/Frame 048033/0287 →
FIRST AMENDMENT TO INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Dec 24, 2014
From: CHEETAH MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 034700/0129 →
SECURITY AGREEMENT Recorded Sep 19, 2011
From: CHEETAH MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 026928/0480 →
CHANGE OF NAME Recorded Apr 17, 2011
From: CHEETAH MEDICAL LTD.
To: CHEETAH MEDICAL HOLDINGS, INC.
Reel/Frame 026139/0287 →
CHANGE OF NAME Recorded Apr 17, 2011
From: CHEETAH MEDICAL HOLDINGS, INC.
To: CHEETAH MEDICAL, INC.
Reel/Frame 026139/0369 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 4, 2010
From: KEREN, HANAN; AVIDOR, YOAV; SQUARA, PIERRE; BURKHOFF, DANIEL; LEVY, BARUCH
To: CHEETAH MEDICAL LTD.
Reel/Frame 024182/0561 →
Continuity (2)
Continuation 11889395 · Aug 13, 2007
Related Publication 20110218419A1 · Sep 8, 2011